De-escalated chemotherapy versus endocrine therapy plus pertuzumab plus trastuzumab for HR+/HER2+early breast cancer (BC): First efficacy results from the neoadjuvant WSG-TP-II study.

Authors
Publication date
1 January 2020
Publisher
AMER SOC CLINICAL ONCOLOGY

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Kölner UniversitätsPublikationsServer

    redirect
    oaioai:USBKOELN.ub.uni-koeln.de:3...
    Last time updated on 08/04/2021